Evaluations of Molecular Diagnostic Biomarkers


Assessment of Molecular Diagnostic Biomarkers A biomarker is a trademark that is even-handedly evaluated and surveyed as a pointer of common biologic methodology, pathogenic techniques, or pharmacologic responses to an accommodating mediation. It used to perceive or avow the proximity of an infirmity or condition of premium or to recognize individuals with a subtype of the ailment.



 


  • PCR enzyme-linked immunosorbent assay
  • Antibodies or proteins
  • Microbial assays
  • Analytical and clinical evaluations
  • Screening

Related Conference of Evaluations of Molecular Diagnostic Biomarkers

August 18-19, 2025

14th World Congress on Biopolymers and Biomaterials

Valencia, Spain
September 22-23, 2025

21st European Organic Chemistry Congress

Dubai, UAE
October 20-21, 2025

8th Global Summit on Polymer Chemistry

Paris, France
October 27-28, 2025

15th International Chemistry Congress

London, UK
November 06-07, 2025

6th World Expo on Biopolymers and Bioplastics

Dubai, UAE
November 13-14, 2025

28th World Congress on Materials Chemistry

Amsterdam, Netherlands
November 26-27, 2025

5th International Conference on Petrochemistry and Natural Gas

Amsterdam, Netherlands
May 14-28, 2025

17th International Conference on Clinical Chemistry

Toronto, Canada
December 08-09, 2025

5th International Conference on Analytical Chemistry

Rome, Italy
December 11-12, 2025

4th World Congress on Plasma Chemistry and Plasma Processing

Amsterdam, Netherlands
December 17-18, 2025

13th International Conference on Catalysis and Chemical Engineering

Aix-en-Provence, France

Evaluations of Molecular Diagnostic Biomarkers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in